April 14-15, 2026 | Hyatt Regency San Francisco Airport
USDM Life Sciences is proud to return to the 2026 American Biomanufacturing Summit, where over 200 biopharma and biotech leaders gather to explore the emerging trends, operational challenges, and technological innovations shaping the future of biotechnology.
As manufacturing complexity increases and regulatory expectations evolve, biomanufacturers must modernize operations without compromising compliance, governance, or quality. At this year’s summit, USDM will demonstrate how Agentic AI and intelligent automation are enabling the next generation of compliant, resilient, and high-performing manufacturing environments.
The Next Era of Biomanufacturing Is Intelligent
Biomanufacturers today face mounting pressures:
- Increasing regulatory scrutiny
- Rising production complexity across global sites
- Data silos between MES, ERP, QMS, and supply chain systems
- Workforce constraints and operational bottlenecks
- Downtime that directly impacts patient supply and revenue
The question is no longer whether to adopt AI. The question is:
How do you implement AI responsibly in regulated manufacturing — while strengthening compliance and operational control? USDM helps life sciences organizations operationalize AI within GxP environments to achieve measurable, transformative outcomes — improving efficiency, minimizing deviations, and maintaining continuous audit-readiness.
If you still need to register, use our VIP code for a discounted pass: USDMVIP!
Meet the USDM Team Onsite
Connect with our executive leaders to discuss your manufacturing modernization roadmap:
- Hovsep Kirikian, VP Strategy & Operations
- Jim Murray, Chief Technology Officer
- Justin Ott, VP Business Development
- Josh Ertmer, Client Services Director
- Lisa Om, VP Marketing
The future of biomanufacturing will be defined by organizations that can:
- Reduce downtime through predictive intelligence
- Optimize workflows across integrated systems
- Strengthen data integrity and governance
- Maintain continuous audit-readiness
- Empower teams with AI-enabled decision support
USDM Life Sciences partners with biotech and biopharma manufacturers to build resilient, intelligent operations that accelerate innovation while protecting compliance.
Fill out the form to schedule a meeting with our SMEs that will be on-site in San Francisco. >>>
We look forward to seeing you there!